Jefferies Comments on Herbalife's (NYSE: HLF) Strong Q2 Results
Tweet Send to a FriendGet Alerts HLF Hot Sheet
Price: $44.44 +0.68%
Rating Summary:
5 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Rating Summary:
5 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Trade HLF Now!
Jefferies is reiterating its Buy rating and $68 price target on shares of Herbalife (NYSE: HLF) following another quarter that was reported ahead of expectations.
The company released its Q2 results with EPS of $0.88, up 35 percent year-over-year and beat the firms forecast by $0.13. Guidance was set at $0.71-$0.74. Sales for the quarter rose 27.7 percent to $879.7 million and was ahead of the firms estimate of 21.6 percent growth. Guidance was set at 19-21 percent growth.
Sales growth was due to strong demand in South and Central America with +57 percent growth and Mexico which experienced +41 percent growth. China was the only region not to grow double digits.
Operating income increased 31.6 percent to $153.2 million, topping the firms estimate of $131.5 million.
Management raised its FY11 EPS guidance $2.77-$2.89 to $2.97-$3.07 and its sales guidance from 18-20 percent growth to 22-24 percent growth. Volumes growth was also increased from 12-14 percent to 15-17 percent.
For Q3, the company is forecasting EPS of $0.71-$0.76 and sales growth of 21-23 percent, with volumes expected to grow 13-15 percent.
For more ratings news on Herbalife click here and for the rating history of Herbalife click here.
Shares of Herbalife closed at $55.54 yesterday, with a 52 week range of $49.10-$108.49.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The company released its Q2 results with EPS of $0.88, up 35 percent year-over-year and beat the firms forecast by $0.13. Guidance was set at $0.71-$0.74. Sales for the quarter rose 27.7 percent to $879.7 million and was ahead of the firms estimate of 21.6 percent growth. Guidance was set at 19-21 percent growth.
Sales growth was due to strong demand in South and Central America with +57 percent growth and Mexico which experienced +41 percent growth. China was the only region not to grow double digits.
Operating income increased 31.6 percent to $153.2 million, topping the firms estimate of $131.5 million.
Management raised its FY11 EPS guidance $2.77-$2.89 to $2.97-$3.07 and its sales guidance from 18-20 percent growth to 22-24 percent growth. Volumes growth was also increased from 12-14 percent to 15-17 percent.
For Q3, the company is forecasting EPS of $0.71-$0.76 and sales growth of 21-23 percent, with volumes expected to grow 13-15 percent.
For more ratings news on Herbalife click here and for the rating history of Herbalife click here.
Shares of Herbalife closed at $55.54 yesterday, with a 52 week range of $49.10-$108.49.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Morgan Stanley Says Tesla (TSLA) 'Top Pick in U.S. Autos'
- Lazard Cuts PT on Aruba (ARUN) to $18; Cisco Pressure Lingers, But Fundamentals Solid
- UBS Survey Shows Signs of Strength for Gilead's (GILD) TAF
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Jefferies & Co
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
